Shares of Basilea Pharmaceutica AG (OTCMKTS:BPMUF – Get Free Report) reached a new 52-week high during trading on Monday . The stock traded as high as $51.26 and last traded at $51.26, with a volume of 1 shares changing hands. The stock had previously closed at $47.00.
Basilea Pharmaceutica Price Performance
The business has a fifty day moving average of $47.83 and a 200 day moving average of $44.74.
Basilea Pharmaceutica Company Profile
Basilea Pharmaceutica AG, a commercial-stage biopharmaceutical company, focuses on the development of products that address the medical needs in the therapeutic areas of oncology and anti-infectives. The company offers Cresemba, an intravenous and antifungal drug for the treatment of invasive aspergillosis and mucormycosis in the United States, and the European Union.
Recommended Stories
- Five stocks we like better than Basilea Pharmaceutica
- 3 Best Fintech Stocks for a Portfolio Boost
- Target Hits the Mark: Q2 Earnings Exceed Expectations
- The Significance of a Trillion-Dollar Market Cap Goes Beyond a Number
- Is Tesla’s Rebound Just Starting? Why You Should Consider Buying
- How to Choose Top Rated Stocks
- Stanley Druckenmiller’s Latest Bet: MELI—Should You Follow Suit?
Receive News & Ratings for Basilea Pharmaceutica Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Basilea Pharmaceutica and related companies with MarketBeat.com's FREE daily email newsletter.
